PHARE randomized trial final results comparing 6 to 12 months of trastuzumab in adjuvant early breast cancer

Affiliation auteurs!!!! Error affiliation !!!!
TitrePHARE randomized trial final results comparing 6 to 12 months of trastuzumab in adjuvant early breast cancer
Type de publicationJournal Article
Year of Publication2019
AuteursPivot X., Romieu G., Debled M., Pierga J-Y, Kerbrat P., Bachelot T., Espie M., Lortholary A., Fumoleau P., Serin D., Jacquin J-P, Jouannaud C., Rios M., Abadie-Lacourtoisie S., Venat-Bouvet L., Cany L., Catala S., Khayat D., Gambotti L., Pauporte I., C. Mercier F, Paget-Bailly S., Henriques J., Grouin J-M
JournalCANCER RESEARCH
Volume79
Date PublishedFEB
Type of ArticleMeeting Abstract
ISSN0008-5472
DOI10.1158/1538-7445.SABCS18-GS2-07